Regencell Bioscience (RGC) has had the highest return this year by a US stock, returning 9,720.4%.

ASSET	YEAR	% RETURN
Regencell Bioscience (RGC)	2025	9,720.36%
CannBioRx Life Sciences (ATNFW)	2025	4,287.76%
DeFi Development (DFDV)	2025	2,677.53%
WW International, Inc Common Stock (WW)	2025	2,322.9%
Blue Gold Limited Warrant (BGLWW)	2025	2,250%
HCM II Acquisition (HONDW)	2025	2,141.38%
CEA Industries (BNCWW)	2025	1,644.97%
Oncology Institute (TOIIW)	2025	1,447.62%
Triumph (TGI)	2025	1,447.6%
K Wave Media (KWMWW)	2025	1,281.55%
Zepp Health (ZEPP)	2025	1,202.31%
Newegg Commerce (NEGG)	2025	1,162.75%
USA Rare Earth (USARW)	2025	1,146%
Diginex Limited Ordinary Shares (DGNX)	2025	1,139.44%
Oncology Institute (TOI)	2025	1,128.76%
CEA Industries (VAPEW)	2025	1,108.05%
Kindly (NAKA)	2025	1,002.42%
SRM Entertainment, Inc Common Stock (SRM)	2025	993.3%
Webull Corporation Warrants (BULLW)	2025	962.71%
Rich Sparkle Holdings Limited Ordinary Shares (ANPA)	2025	913.89%
Abivax SA American Depositary Shares (ABVX)	2025	872.93%
Anbio Biotechnology Class A Ordinary Shares (NNNN)	2025	867.87%
Ainos (AIMDW)	2025	853.55%
Global Interactive Technologies (GITS)	2025	821.16%
CID HoldCo, Inc Warrants (DAICW)	2025	795%